KR:NYSEKroger Company (The) Analysis
Data as of 2026-03-10 - not real-time
$73.37
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Kroger delivered Q4 earnings of $1.28 per share, beating the Zacks consensus of $1.20 and expanding margins, which helped push the stock to $73.37, comfortably above its 20‑day (≈69.3) and 50‑day (≈65.4) simple moving averages. The technical picture is bullish, with the MACD line (≈1.71) sitting above its signal (≈1.34) and a positive histogram, while the RSI at 65 signals near‑term strength but also hints at overbought conditions. Analyst sentiment remains positive, with a consensus “buy” rating and a median price target of $73, closely matching the current price.
Despite the short‑term momentum, the stock appears **overvalued**: the DCF fair value of roughly $43 is far below the market price, and the trailing P/E of 47.6 dwarfs the forward P/E of 13.0. The dividend yield of 1.9% is supported by an 87% payout ratio, raising questions about long‑term sustainability given thin profit margins (≈0.7%) and a very high debt‑to‑equity ratio (>400%). The company’s strong free cash flow and ongoing share repurchase program provide some cushion, but the combination of high valuation, leverage, and modest growth suggests caution for longer horizons.
Despite the short‑term momentum, the stock appears **overvalued**: the DCF fair value of roughly $43 is far below the market price, and the trailing P/E of 47.6 dwarfs the forward P/E of 13.0. The dividend yield of 1.9% is supported by an 87% payout ratio, raising questions about long‑term sustainability given thin profit margins (≈0.7%) and a very high debt‑to‑equity ratio (>400%). The company’s strong free cash flow and ongoing share repurchase program provide some cushion, but the combination of high valuation, leverage, and modest growth suggests caution for longer horizons.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Q4 earnings beat and margin expansion
- Bullish MACD and price above key moving averages
- Stable trading volume supporting liquidity
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Forward earnings growth (trailing EPS $1.54 → forward EPS $5.65)
- Attractive dividend yield but high payout ratio
- Share repurchase program reducing share count
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Significant overvaluation relative to DCF fair value
- Very high debt‑to‑equity ratio and thin profit margins
- Uncertainty around dividend sustainability
Key Metrics & Analysis
Financial Health
Revenue Growth1.20%
Profit Margin0.69%
P/E Ratio47.6
ROE14.41%
ROA5.64%
Debt/Equity415.77
P/B Ratio5.9
Op. Cash Flow$7.3B
Free Cash Flow$3.4B
Technical Analysis
TrendNeutral
RSI65.1
Support$66.04
Resistance$74.85
MA 20$69.32
MA 50$65.41
MA 200$67.19
MACDBullish
VolumeStable
Fear & Greed Index77.64
Valuation
Fair Value$43.21
Target Price$74.38
Upside/Downside1.38%
GradeOvervalued
TypeGrowth
Dividend Yield1.91%
Risk Assessment
Beta-0.28
Volatility34.58%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.